These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 30870347)

  • 1. The Clinical Outcomes After Intratympanic Gentamicin Injection to Treat Menière's Disease: A Meta-analysis.
    Zhang Y; Fu J; Lin H; Shen C; Wang X; Wu J
    Otol Neurotol; 2019 Apr; 40(4):419-429. PubMed ID: 30870347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intratympanic Treatment in Menière's Disease, Efficacy of Aminoglycosides Versus Corticosteroids in Comparison Studies: A Systematic Review.
    Yaz F; Ziylan F; Smeeing DPJ; Thomeer HGXM
    Otol Neurotol; 2020 Jan; 41(1):1-10. PubMed ID: 31789967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-dose intratympanic gentamicin instillations for treatment of Meniere's disease: long-term results.
    Hsieh LC; Lin HC; Tsai HT; Ko YC; Shu MT; Lin LH
    Acta Otolaryngol; 2009 Dec; 129(12):1420-4. PubMed ID: 19922092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes of intratympanic gentamicin injection to treat Ménière's disease.
    Huon LK; Fang TY; Wang PC
    Otol Neurotol; 2012 Jul; 33(5):706-14. PubMed ID: 22699980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Instrumental head impulse test changes after intratympanic gentamicin for unilateral definite Ménière's disease: A systematic review and meta-analysis.
    Marques PS; Dias CC; Perez-Fernandez N; Spratley J
    Auris Nasus Larynx; 2018 Oct; 45(5):943-951. PubMed ID: 29402608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of intractable Ménière's disease after intratympanic injection of gentamicin.
    Rah YC; Han JJ; Park J; Choi BY; Koo JW
    Laryngoscope; 2015 Apr; 125(4):972-8. PubMed ID: 25363447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intratympanic gentamicin for Menière's disease: a meta-analysis.
    Cohen-Kerem R; Kisilevsky V; Einarson TR; Kozer E; Koren G; Rutka JA
    Laryngoscope; 2004 Dec; 114(12):2085-91. PubMed ID: 15564826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term hearing outcome in patients receiving intratympanic gentamicin for Ménière's disease.
    Wu IC; Minor LB
    Laryngoscope; 2003 May; 113(5):815-20. PubMed ID: 12792316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different medications for the treatment of Ménière's disease by intratympanic injection: A systematic review and network meta-analysis.
    Cao Z; Yue F; Huang W; Rajenderkumar D; Zhao F
    Clin Otolaryngol; 2019 Jul; 44(4):619-627. PubMed ID: 31025490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intratympanic mixture gentamicin and dexamethasone versus dexamethasone for unilateral Meniere's disease.
    Öztürk K; Ata N
    Am J Otolaryngol; 2019; 40(5):711-714. PubMed ID: 31262549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modified titration intratympanic gentamicin injection for unilateral intractable Ménière's disease.
    Liu B; Leng YM; Shi H; Zhou RH; Liu JJ; Zhang WJ; Zhang SL; Kong WJ
    J Huazhong Univ Sci Technolog Med Sci; 2015 Oct; 35(5):747-751. PubMed ID: 26489633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intratympanic gentamicin for control of vertigo in Meniere's disease: vestibular signs that specify completion of therapy.
    Minor LB
    Am J Otol; 1999 Mar; 20(2):209-19. PubMed ID: 10100525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vestibular results after intratympanic gentamicin therapy in disabling Menière's disease.
    Junet P; Karkas A; Dumas G; Quesada JL; Schmerber S
    Eur Arch Otorhinolaryngol; 2016 Oct; 273(10):3011-8. PubMed ID: 26780342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endolymphatic sac surgery versus intratympanic gentamicin for the treatment of intractable Ménière's disease: a retrospective review with survey.
    Paradis J; Hu A; Parnes LS
    Otol Neurotol; 2013 Oct; 34(8):1434-7. PubMed ID: 23846192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of prior intratympanic gentamicin and corticosteroids therapy on speech understanding in patients with Menière's disease after cochlear implantation.
    Thangavelu K; Gillhausen F; Weiß RM; Mueller-Mazzotta J; Stuck BA; Reimann K
    Eur Arch Otorhinolaryngol; 2024 Jul; 281(7):3483-3490. PubMed ID: 38302621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. End-point indicators of low-dose intra-tympanic gentamicin in management of Ménière's disease.
    Liu H; Zhang T; Wu Q; Zhang Y; Dai C
    Acta Otolaryngol; 2017 Feb; 137(2):136-143. PubMed ID: 27608722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intratympanic gentamicin for intractable Meniere's disease.
    Perez N; Martín E; García-Tapia R
    Laryngoscope; 2003 Mar; 113(3):456-64. PubMed ID: 12616197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intratympanic gentamicin for Ménière's disease: effect on quality of life as assessed by Glasgow benefit inventory.
    Banerjee AS; Johnson IJ
    J Laryngol Otol; 2006 Oct; 120(10):827-31. PubMed ID: 16707038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of endolymphatic shunt surgery and intratympanic gentamicin for meniere's disease.
    Gibson AW; Moon IJ; Golub JS; Rubinstein JT
    Laryngoscope; 2020 Oct; 130(10):2455-2460. PubMed ID: 31808957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CASP9 genotype confers gentamicin susceptibility in intratympanic treatment of intractable vertigo caused by Ménière's disease.
    Huang CJ; Wan TK; Fang TY; Wang PC
    Acta Otolaryngol; 2019 Apr; 139(4):336-339. PubMed ID: 30907242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.